Forian

Forian EV/EBIT

Delisted

The EV/EBIT (Enterprise Value to EBIT) of Forian (FORA) as of Nov 22, 2026 is -11.74. In the previous year, EV/EBIT (Enterprise Value to EBIT) was -17.88 — a change of -34.36% (higher).

EV/EBIT

-11.74

YoY

-34.36%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Forian is 2024 -11.74 . EV/EBIT (Enterprise Value to EBIT) of Forian was 2023 -17.88 . It decreases by -34.36% higher compared to the previous year.

The Forian EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBIT
Date
EV/EBIT
Jan 1, 2019
-6.38 USD
Jan 1, 2020
-13.10 USD
Jan 1, 2021
-2.47 USD
Jan 1, 2022
-2.52 USD
Jan 1, 2023
-17.88 USD
Jan 1, 2024
-11.74 USD
Jan 1, 2025 (e)
-26.84 USD
Jan 1, 2026 (e)
-30.73 USD
The Forian EV/EBIT history
YEAREV/EBITYoY
est-30.73+14.49%
est-26.84+128.71%
-11.74-34.36%
-17.88+610.41%
-2.52+1.85%
-2.47-81.14%
-13.10+105.22%
-6.38-1.66%
-6.49-62.39%
-17.26-31.75%
-25.29-87.21%
-197.73—
0.00—
0.00—
0.00—
0.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Forian Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Forian's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Forian's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Forian's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Forian grows earnings faster than its peers.

Forian Stock analysis

What does Forian do? Forian, Inc. generates revenue through its Information and Software segment, which licenses data management and analytics products to healthcare life sciences, payer, and provider customers. The Services segment offers implementation, support, and training services on a contractual basis to these same segments. The Other segment provides security and marketing services, primarily through its security and marketing operations. The company's data management solution organizes, normalizes, standardizes, integrates, enhances, and publishes transactional information for customers across traditional and emerging healthcare sectors. Patient registries solutions help clients understand disease progression, treatment protocols, and therapeutic effectiveness through data-driven insights. Forian's customers within the healthcare payer and provider segments purchase its data management capabilities and analytics tools to optimize operational, clinical, and financial performance. The life sciences segment uses its information and software products for research and development purposes. The company's services include implementation, support, and training, which are contracted by customers seeking to integrate Forian's solutions into their workflows. Security and marketing services in the Other segment are provided to support broader business operations. The Information and Software segment licenses products that include data management and analytics solutions tailored for healthcare organizations. Services segment contracts focus on implementation, support, and training for customers using these solutions. The Other segment's security and marketing services are secondary operations that complement the primary business model. Forian's offerings enable healthcare organizations to measure performance across clinical, operational, and financial dimensions through standardized data processes. Forian is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Forian stock

EV/EBIT (Enterprise Value to EBIT) of Forian is -11.74 in 2024.

EV/EBIT (Enterprise Value to EBIT) of Forian changed from -17.88 to -11.74, representing a -34.36% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Forian since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Forian with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Forian

All Key Metrics — Forian